140 related articles for article (PubMed ID: 8928539)
21. [Glucagonoma syndrome report of one case and review of the chinese literature].
Xu SM; Peng SY; Chen PH
Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):565-7. PubMed ID: 7720433
[TBL] [Abstract][Full Text] [Related]
22. Treatment of metastatic glucagonoma to the liver: case report and literature review.
Casadei R; Tomassetti P; Rossi C; la Donna M; Migliori M; Marrano D
Ital J Gastroenterol Hepatol; 1999 May; 31(4):308-12. PubMed ID: 10425577
[TBL] [Abstract][Full Text] [Related]
23. Dermatitis, glossitis, stomatitis, cheilitis, anemia and weight loss: a classic presentation of pancreatic glucagonoma.
Povoski SP; Zaman SA; Ducatman BS; McFadden DW
W V Med J; 2002; 98(1):12-4. PubMed ID: 11941895
[TBL] [Abstract][Full Text] [Related]
24. Malignant glucagonoma of the pancreas diagnoses through anemia and diabetes mellitus.
Koike N; Hatori T; Imaizumi T; Harada N; Fukuda A; Takasaki K; Iwamoto Y
J Hepatobiliary Pancreat Surg; 2003; 10(1):101-5. PubMed ID: 12918465
[TBL] [Abstract][Full Text] [Related]
25. Clinical experience in diagnosis and treatment of glucagonoma syndrome.
Zhang M; Xu X; Shen Y; Hu ZH; Wu LM; Zheng SS
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):473-5. PubMed ID: 15313692
[TBL] [Abstract][Full Text] [Related]
26. The glucagonoma syndrome. Report of a case.
Domen RE; Shaffer MB; Finke J; Sterin WK; Hurst CB
Arch Intern Med; 1980 Feb; 140(2):262-3. PubMed ID: 6243459
[TBL] [Abstract][Full Text] [Related]
27. Octreotide-responsive necrolytic migratory erythema in a patient with pseudoglucagonoma syndrome.
Virani S; Prajapati V; Devani A; Mahmood MN; Elliott JF
J Am Acad Dermatol; 2013 Feb; 68(2):e44-6. PubMed ID: 23317985
[No Abstract] [Full Text] [Related]
28. Necrolytic migratory erythema associated with hyperglucagonemia and neuroendocrine hepatic tumors.
Marko PB; Miljković J; Zemljic TG
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Dec; 14(4):161-4, 166. PubMed ID: 16435046
[TBL] [Abstract][Full Text] [Related]
29. Combined liver and pancreas resection with biochemotherapy for metastatic ocular melanoma.
Camp R; Lind DS; Hemming AW
J Hepatobiliary Pancreat Surg; 2002; 9(4):519-21. PubMed ID: 12483277
[TBL] [Abstract][Full Text] [Related]
30. A case of glucagonoma at the uncinate process of the pancreas successfully treated by pancreaticoduodenectomy.
Yamamoto S; Tanaka H; Asai Y; Wakasa K; Takemura S; Hai S; Ichikawa T; Kodai S; Shinkawa H; Kubo S
Pancreas; 2008 Jan; 36(1):100-2. PubMed ID: 18192893
[No Abstract] [Full Text] [Related]
31. [Glucagonoma: case report and literature review].
das Neves MM; Martins Júnior EV; Gaburri AK; Chebli JM; Stávale JN; Herani Filho AK
Arq Gastroenterol; 1996; 33(3):167-72. PubMed ID: 9201330
[TBL] [Abstract][Full Text] [Related]
32. Metastatic glucagonoma: treatment with liver transplantation.
Radny P; Eigentler TK; Soennichsen K; Overkamp D; Raab HR; Viebahn R; Mueller-Horvart C; Sotlar K; Rassner G
J Am Acad Dermatol; 2006 Feb; 54(2):344-7. PubMed ID: 16443073
[TBL] [Abstract][Full Text] [Related]
33. [The glucagonoma syndrome--a not-so-well-known cutaneous paraneoplastic condition. Case report].
Galle K; Schweiss D
Hautarzt; 1984 Apr; 35(4):204-9. PubMed ID: 6327570
[TBL] [Abstract][Full Text] [Related]
34. [The glucagonoma syndrome. 3 new cases].
Arnaud A; Fetissof F; Lorette G; Reigner J; Bertrand G; Lecomte P
Rev Med Interne; 1992; 13(2):103-8. PubMed ID: 1410882
[TBL] [Abstract][Full Text] [Related]
35. Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour.
Eldor R; Glaser B; Fraenkel M; Doviner V; Salmon A; Gross DJ
Clin Endocrinol (Oxf); 2011 May; 74(5):593-8. PubMed ID: 21470282
[TBL] [Abstract][Full Text] [Related]
36. [A clinical analysis of glucagonoma syndrome (four cases reported)].
Ma DL; Zeng JY; Wang BX; Fang K
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):210-3. PubMed ID: 12905724
[TBL] [Abstract][Full Text] [Related]
37. The glucagonoma syndrome.
Wynick D; Hammond PJ; Bloom SR
Clin Dermatol; 1993; 11(1):93-7. PubMed ID: 8339206
[No Abstract] [Full Text] [Related]
38. Reversal of a neurologic paraneoplastic syndrome with octreotide (Sandostatin) in a patient with glucagonoma.
Holmes A; Kilpatrick C; Proietto J; Green MD
Am J Med; 1991 Oct; 91(4):434-6. PubMed ID: 1951389
[TBL] [Abstract][Full Text] [Related]
39. Migratory necrolytic erythema and glucagonoma.
Echenique-Elizondo M; Elorza JL; De Delas JS
Surgery; 2003 Apr; 133(4):449-50. PubMed ID: 12717367
[No Abstract] [Full Text] [Related]
40. The surgical and systemic management of neuroendocrine tumors of the pancreas.
Abood GJ; Go A; Malhotra D; Shoup M
Surg Clin North Am; 2009 Feb; 89(1):249-66, x. PubMed ID: 19186239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
